Skip to main content

Security report for testlinecd.de

TestLine Clinical Diagnostics s.r.o. · Healthcare · Czech Republic

Medium risk. 8 critical or high findings in GDPR outside view, Security headers and 3 other checks.

Security score

51/100

Risk levelMedium

0–100, higher is better. How it is calculated

TestLine Clinical Diagnostics s.r.o. is a medium-sized healthcare company specializing in the development, production, and distribution of in vitro diagnostic products for human and veterinary use. The company operates as part of the BioVendor Group, an international biotechnology conglomerate, enhancing its market position and credibility. Their website provides comprehensive product information, quality certificates, and customer service resources targeting healthcare professionals and laboratories. The business model focuses on innovation and quality in clinical diagnostics, supported by a professional online presence with multilingual support.

Scanned

NIS2 and GDPR posture

GDPR outside view
25/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

    • High

      Third-party services without privacy policy

      Detected services: Google Analytics, LinkedIn, YouTube, Google APIs

      What to do: Document all third-party data sharing in your privacy policy

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching testlinecd.de

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
65
Email security
65
DNS health
70
Network security
20
GDPR outside view
25
Average
51

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention testlinecd.de, from OffSeq Breach.

No leaked records found

Breach holds no records for testlinecd.de right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company holds a solid position within the biotechnology and healthcare diagnostics sector, leveraging its affiliation with the BioVendor Group to access broader markets and resources. Their product portfolio includes advanced diagnostic kits and multiplex testing solutions, indicating a focus on innovation and specialized laboratory services. The presence of multiple related domains and partnerships with other biotech brands suggests a well-integrated ecosystem. The company targets clinical laboratories and healthcare providers, emphasizing quality certifications and regulatory compliance such as IVDR. Growth indicators include participation in international events and continuous product launches.

Security posture

The website demonstrates a good security posture with HTTPS enforced and a cookie consent mechanism aligned with GDPR requirements. However, there is a lack of explicit security policies or incident response information publicly available, which could be improved to enhance transparency and trust. The use of an older jQuery version presents a minor vulnerability risk. No exposed sensitive data or obvious vulnerabilities were detected in the website content. Security headers are not explicitly present, representing an area for improvement. Overall, the security maturity is moderate to good but could benefit from enhanced security documentation and updated libraries.

Recommendations

  1. Implement comprehensive security headers such as Content Security Policy (CSP), HSTS, and X-Frame-Options to strengthen defense against common web attacks.
  2. Publish explicit security and incident response policies on the website to improve transparency and preparedness.
  3. Upgrade JavaScript libraries, especially jQuery, to the latest secure versions to mitigate known vulnerabilities.
  4. Introduce a vulnerability disclosure policy or security.txt file to facilitate responsible reporting of security issues.
  5. Continue enhancing privacy compliance by detailing data retention policies and expanding user control over data.

Contact details published on the site

Addresses
Legal name
TestLine Clinical Diagnostics s.r.o.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
TestLine Clinical Diagnostics s.r.o.
Description
TestLine Clinical Diagnostics s.r.o. - Erstellung, Produktion und Vertrieb von Labordiagnostik für den menschlichen oder veterinären Einsatz
Key services
Lab diagnostics production, Distribution of IVD products, Quality certificates and product documentation access
Content quality
good
Branding
consistent

Technology

Stack
HTML5, CSS3, JavaScript, jQuery 1.11.1, Google Fonts, Typekit Fonts, ResponsiveSlides.js, PrettyPhoto, Cookies.js
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data in HTML
  • Login form uses POST method

Analytics and tracking

Services
Google Analytics
Tracking level
minimal
Privacy practices
good

Advertising

Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Content is professional and focused on clinical diagnostics products.
  3. Cookie consent and privacy policies are implemented and GDPR compliant.
  4. No explicit security policies or incident response information publicly available.
  5. Use of older jQuery version may pose minor security risk.
  6. Strong branding consistency and clear contact information.
  7. Part of a larger biotechnology group with multiple related domains.
  8. No evidence of suspicious or malicious content.
Technical notes

Notes

The website uses a traditional web technology stack including HTML5, CSS3, and JavaScript with jQuery 1.11.1, supplemented by various plugins for responsive slides, photo galleries, and cookie management. Fonts are loaded from Google Fonts and Adobe Typekit, ensuring good typography. The site is mobile optimized with responsive design elements and clear navigation. Performance is moderate, with no major issues detected. SEO is supported by proper meta tags and Open Graph data. There is no detected CMS, suggesting a custom or static site architecture. Hosting details are not explicit but DNS indicates Czech hosting providers. Technical risks include the use of outdated JavaScript libraries and absence of advanced security headers.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with testlinecd.de. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review testlinecd.de.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.